Cargando…
Very Short Versus Longer Dual Antiplatelet Treatment After Coronary Interventions: A Systematic Review and Meta-analysis
BACKGROUND: Very short (≤ 3 months) duration of dual antiplatelet therapy (VSDAPT) has recently been proposed after percutaneous coronary intervention (PCI) with drug-eluting stent (DES). OBJECTIVES: The aim of this systematic review and meta-analysis was to compare very short versus > 3 months’...
Autores principales: | Tsigkas, Grigorios, Apostolos, Anastasios, Trigka, Aikaterini, Chlorogiannis, Dimitrios, Katsanos, Konstantinos, Toutouzas, Konstantinos, Alexopoulos, Dimitrios, Brilakis, Emmanouil S., Davlouros, Periklis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845152/ https://www.ncbi.nlm.nih.gov/pubmed/36536171 http://dx.doi.org/10.1007/s40256-022-00559-0 |
Ejemplares similares
-
Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis
por: Tsigkas, Grigorios, et al.
Publicado: (2023) -
Angiographic estimation of atherosclerotic disease burden in a coronary artery fed by collaterals: a potential pitfall in decision for revascularization
por: Tsigkas, Grigorios, et al.
Publicado: (2011) -
Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review
por: Tsigkas, Grigorios, et al.
Publicado: (2023) -
Coronary fistulae behind an abnormal electrocardiogram interpretation: an unexpected guest
por: Tsigkas, Grigorios, et al.
Publicado: (2020) -
Incidence, pathophysiology, predictive factors and prognostic implications of new onset atrial fibrillation following transcatheter aortic valve implantation
por: Koniari, Ioanna, et al.
Publicado: (2018)